260 related articles for article (PubMed ID: 31705405)
1. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.
Saito T; Muragaki Y; Maruyama T; Komori T; Nitta M; Tsuzuki S; Fukui A; Kawamata T
Neurosurg Rev; 2020 Dec; 43(6):1583-1593. PubMed ID: 31705405
[TBL] [Abstract][Full Text] [Related]
2. Malignancy Index Using Intraoperative Flow Cytometry is a Valuable Prognostic Factor for Glioblastoma Treated With Radiotherapy and Concomitant Temozolomide.
Saito T; Muragaki Y; Shioyama T; Komori T; Maruyama T; Nitta M; Yasuda T; Hosono J; Okamoto S; Kawamata T
Neurosurgery; 2019 Mar; 84(3):662-672. PubMed ID: 29618055
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients.
Saito T; Sugiyama K; Hama S; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
Neurosurg Rev; 2018 Apr; 41(2):621-628. PubMed ID: 28887717
[TBL] [Abstract][Full Text] [Related]
5. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
[TBL] [Abstract][Full Text] [Related]
6. Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.
Berger K; Turowski B; Felsberg J; Malzkorn B; Reifenberger G; Steiger HJ; Budach W; Haussmann J; Knipps J; Rapp M; Hänggi D; Sabel M; Mijderwijk HJ; Kamp MA
J Cancer Res Clin Oncol; 2021 Jan; 147(1):253-262. PubMed ID: 32748120
[TBL] [Abstract][Full Text] [Related]
7. Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Schwartz C; Romagna A; Machegger L; Weiss L; Huemer F; Fastner G; Kleindienst W; Weis S; Greil R; Winkler PA
World Neurosurg; 2018 Dec; 120():442-447. PubMed ID: 30253992
[TBL] [Abstract][Full Text] [Related]
8. High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas.
Saito T; Sugiyama K; Hama S; Yamasaki F; Takayasu T; Nosaka R; Onishi S; Muragaki Y; Kawamata T; Kurisu K
World Neurosurg; 2017 Sep; 105():282-288. PubMed ID: 28602885
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
Roh TH; Park HH; Kang SG; Moon JH; Kim EH; Hong CK; Ahn SS; Choi HJ; Cho J; Kim SH; Lee SK; Kim DS; Kim SH; Suh CO; Lee KS; Chang JH
Medicine (Baltimore); 2017 Jul; 96(27):e7422. PubMed ID: 28682902
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis.
Behling F; Kaltenstadler M; Noell S; Schittenhelm J; Bender B; Eckert F; Tabatabai G; Tatagiba M; Skardelly M
World Neurosurg; 2017 Oct; 106():615-624. PubMed ID: 28729143
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
Younis SG; Khedr RA; El-Shorbagy SH
J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.
Yang K; Man W; Jing L; Sun Z; Liang P; Wang J; Wang G
World Neurosurg; 2020 Nov; 143():e157-e165. PubMed ID: 32688042
[TBL] [Abstract][Full Text] [Related]
14. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
15. Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma.
Hallaert G; Pinson H; Van den Broecke C; Sweldens C; Van Roost D; Kalala JP; Boterberg T
Acta Oncol; 2021 May; 60(5):613-619. PubMed ID: 33689536
[TBL] [Abstract][Full Text] [Related]
16. Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival.
Mistry AM; Kelly PD; Gallant JN; Mummareddy N; Mobley BC; Thompson RC; Chambless LB
Neurosurgery; 2019 Nov; 85(5):E924-E932. PubMed ID: 31058968
[TBL] [Abstract][Full Text] [Related]
17. The association of subventricular zone involvement at recurrence with survival after repeat surgery in patients with recurrent glioblastoma.
Sonoda Y; Saito R; Kanamori M; Kumabe T; Uenohara H; Tominaga T
Neurol Med Chir (Tokyo); 2014; 54(4):302-9. PubMed ID: 24390189
[TBL] [Abstract][Full Text] [Related]
18. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
[TBL] [Abstract][Full Text] [Related]
19. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
20. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
Yan JL; van der Hoorn A; Larkin TJ; Boonzaier NR; Matys T; Price SJ
J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
